Current status and future perspective of structural heart disease intervention

Journal of Cardiology

Volumn 74, Issue 1, 2019, Pages 1-12

  Tabata, Noriaki ^a,b   Sinning, Jan Malte ^a   Kaikita, Koichi ^b   Tsujita, Kenichi ^b   Nickenig, Georg ^a   Werner, Nikos ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

mitral regurgitation; structural heart disease intervention; transcatheter aortic valve implantation; tricuspid regurgitation

Indexed keywords

ANNULOPLASTY; AORTIC REGURGITATION; AORTIC STENOSIS; AORTIC VALVE; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; ATRIAL FIBRILLATION; BIOMECHANICS; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOPULMONARY BYPASS; CEREBROVASCULAR ACCIDENT; CLINICAL OUTCOME; CORONARY ARTERY DISEASE; DEVICE SAFETY; DISEASE SEVERITY; EUROSCORE; FOLLOW UP; HEART DEATH; HEART DISEASE; HEART FAILURE; HEART RIGHT VENTRICLE FAILURE; HOSPITALIZATION; HUMAN; INTERVENTION STUDY; ISCHEMIC CARDIOMYOPATHY; ISCHEMIC STROKE; MITRAL VALVE DISEASE; MITRAL VALVE REGURGITATION; MITRAL VALVE STENOSIS; MORTALITY; OUTCOME ASSESSMENT; PACEMAKER IMPLANTATION; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RIGHT CORONARY ARTERY; RISK ASSESSMENT; RISK FACTOR; SINUS RHYTHM; THORACOTOMY; THREE DIMENSIONAL ECHOCARDIOGRAPHY; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSCATHETER EDGE TO EDGE MITRAL VALVE REPAIR; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRICUSPID VALVE; TRICUSPID VALVE REGURGITATION; AGED; FEMALE; FORECASTING; HEART VALVE; HEART VALVE REPLACEMENT; MALE; MINIMALLY INVASIVE SURGERY; PROCEDURES; TREATMENT OUTCOME; VALVULAR HEART DISEASE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; FORECASTING; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HEART VALVES; HUMANS; MALE; MINIMALLY INVASIVE SURGICAL PROCEDURES; PATIENT SELECTION; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME;

EID: 85063870104     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2019.02.022     Document Type: Review

References (126)

1. Wilson, P.W., An epidemiologic perspective of systemic hypertension, ischemic heart disease, and heart failure. Am J Cardiol, 80, 1997 3J–8J.
2. Mangion, J.R., Tighe, D.A., Aortic valvular disease in adults. Postgrad Med 98 (1995), 127–140.
3. Grigioni, F., Enriquez-Sarano, M., Ling, L.H., Bailey, K.R., Seward, J.B., Tajik, A.J., et al. Sudden death in mitral regurgitation due to flail leaflet. J Am Coll Cardiol 34 (1999), 2078–2085.
4. Supino, P.G., Borer, J.S., Preibisz, J., Bornstein, A., The epidemiology of valvular heart disease: a growing public health problem. Heart Fail Clin 2 (2006), 379–393.
5. Pibarot, P., Dumesnil, J.G., Prosthetic heart valves: selection of the optimal prosthesis and long-term management. Circulation 119 (2009), 1034–1048.
6. Brown, M.L., Pellikka, P.A., Schaff, H.V., Scott, C.G., Mullany, C.J., Sundt, T.M., et al. The benefits of early valve replacement in asymptomatic patients with severe aortic stenosis. J Thorac Cardiovasc Surg 135 (2008), 308–315.
7. Pai, R.G., Kapoor, N., Bansal, R.C., Varadarajan, P., Malignant natural history of asymptomatic severe aortic stenosis: benefit of aortic valve replacement. Ann Thorac Surg 82 (2006), 2116–2122.
8. Cribier, A., Eltchaninoff, H., Bash, A., Borenstein, N., Tron, C., Bauer, F., et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106 (2002), 3006–3008.
9. Blackstone, E.H., Suri, R.M., Rajeswaran, J., Babaliaros, V., Douglas, P.S., Fearon, W.F., et al. Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy. Circulation 131 (2015), 1989–2000.
10. Leon, M.B., Smith, C.R., Mack, M., Miller, D.C., Moses, J.W., Svensson, L.G., et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363 (2010), 1597–1607.
11. Smith, C.R., Leon, M.B., Mack, M.J., Miller, D.C., Moses, J.W., Svensson, L.G., et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364 (2011), 2187–2198.
12. Popma, J.J., Adams, D.H., Reardon, M.J., Yakubov, S.J., Kleiman, N.S., Heimansohn, D., et al. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol 63 (2014), 1972–1981.
13. Adams, D.H., Popma, J.J., Reardon, M.J., Yakubov, S.J., Coselli, J.S., Deeb, G.M., et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 370 (2014), 1790–1798.
14. Latib, A., Maisano, F., Bertoldi, L., Giacomini, A., Shannon, J., Cioni, M., et al. Transcatheter vs surgical aortic valve replacement in intermediate-surgical-risk patients with aortic stenosis: a propensity score-matched case-control study. Am Heart J 164 (2012), 910–917.
15. D'Errigo, P., Barbanti, M., Ranucci, M., Onorati, F., Covello, R.D., Rosato, S., et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis: results from an intermediate risk propensity-matched population of the Italian OBSERVANT study. Int J Cardiol 167 (2013), 1945–1952.
16. Piazza, N., Kalesan, B., van Mieghem, N., Head, S., Wenaweser, P., Carrel, T.P., et al. A 3-center comparison of 1-year mortality outcomes between transcatheter aortic valve implantation and surgical aortic valve replacement on the basis of propensity score matching among intermediate-risk surgical patients. JACC Cardiovasc Interv 6 (2013), 443–451.
17. Leon, M.B., Smith, C.R., Mack, M.J., Makkar, R.R., Svensson, L.G., Kodali, S.K., et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 374 (2016), 1609–1620.
18. Reardon, M.J., Van Mieghem, N.M., Popma, J.J., Kleiman, N.S., Sondergaard, L., Mumtaz, M., et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med 376 (2017), 1321–1331.
19. Thourani, V.H., Kodali, S., Makkar, R.R., Herrmann, H.C., Williams, M., Babaliaros, V., et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet 387 (2016), 2218–2225.
20. Abdel-Wahab, M., Neumann, F.J., Mehilli, J., Frerker, C., Richardt, D., Landt, M., et al. 1-Year outcomes after transcatheter aortic valve replacement with balloon-expandable versus self-expandable valves: results from the CHOICE randomized clinical trial. J Am Coll Cardiol 66 (2015), 791–800.
21. Meredith Am, I.T., Walters, D.L., Dumonteil, N., Worthley, S.G., Tchetche, D., Manoharan, G., et al. Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study. J Am Coll Cardiol 64 (2014), 1339–1348.
22. Rampat, R., Khawaja, M.Z., Byrne, J., MacCarthy, P., Blackman, D.J., Krishnamurthy, A., et al. Transcatheter aortic valve replacement using the repositionable LOTUS valve: United Kingdom experience. JACC Cardiovasc Interv 9 (2016), 367–372.
23. Meredith, I.T., Walters, D.L., Dumonteil, N., Worthley, S.G., Tchetche, D., Manoharan, G., et al. 1-Year outcomes with the fully repositionable and retrievable lotus transcatheter aortic replacement valve in 120 high-risk surgical patients with severe aortic stenosis: results of the REPRISE II study. JACC Cardiovasc Interv 9 (2016), 376–384.
24. Meredith, I.T., Worthley, S.G., Whitbourn, R.J., Antonis, P., Montarello, J.K., Newcomb, A.E., et al. Transfemoral aortic valve replacement with the repositionable Lotus Valve System in high surgical risk patients: the REPRISE I study. EuroIntervention 9 (2014), 1264–1270.
25. Gooley, R.P., Talman, A.H., Cameron, J.D., Lockwood, S.M., Meredith, I.T., Comparison of self-expanding and mechanically expanded transcatheter aortic valve prostheses. JACC Cardiovasc Interv 8 (2015), 962–971.
26. Wohrle, J., Gonska, B., Rodewald, C., Seeger, J., Scharnbeck, D., Rottbauer, W., Transfemoral aortic valve implantation with the repositionable Lotus valve for treatment of patients with symptomatic severe aortic stenosis: results from a single-centre experience. EuroIntervention 12 (2016), 760–767.
27. Kempfert, J., Treede, H., Rastan, A.J., Schonburg, M., Thielmann, M., Sorg, S., et al. Transapical aortic valve implantation using a new self-expandable bioprosthesis (ACURATE TA): 6-month outcomes. Eur J Cardiothorac Surg 43 (2013), 52–56.
28. Kempfert, J., Holzhey, D., Hofmann, S., Girdauskas, E., Treede, H., Schrofel, H., et al. First registry results from the newly approved ACURATE TA TAVI systemdagger. Eur J Cardiothorac Surg 48 (2015), 137–141.
29. Schafer, U., Conradi, L., Diemert, P., Deuschl, F., Schofer, N., Seiffert, M., et al. ACURATE TAVI: review of the technology, developments and current data with this self-expanding transcatheter heart valve. Minerva Cardioangiol 63 (2015), 359–369.
30. Mollmann, H., Hengstenberg, C., Hilker, M., Kerber, S., Schafer, U., Rudolph, T., et al. Real-world experience using the ACURATE neo prosthesis: 30-day outcomes of 1,000 patients enrolled in the SAVI TF registry. EuroIntervention 13 (2018), e1764–e1770.
31. Kim, W.K., Hengstenberg, C., Hilker, M., Kerber, S., Schafer, U., Rudolph, T., et al. The SAVI-TF Registry: 1-year outcomes of the European Post-Market Registry using the ACURATE neo transcatheter heart valve under real-world conditions in 1,000 patients. JACC Cardiovasc Interv 11 (2018), 1368–1374.
32. Seiffert, M., Diemert, P., Koschyk, D., Schirmer, J., Conradi, L., Schnabel, R., et al. Transapical implantation of a second-generation transcatheter heart valve in patients with noncalcified aortic regurgitation. JACC Cardiovasc Interv 6 (2013), 590–597.
33. Wenaweser, P., Stortecky, S., Schutz, T., Praz, F., Gloekler, S., Windecker, S., et al. Transcatheter aortic valve implantation with the NVT Allegra transcatheter heart valve system: first-in-human experience with a novel self-expanding transcatheter heart valve. EuroIntervention 12 (2016), 71–77.
34. Rosato, S., Santini, F., Barbanti, M., Biancari, F., D'Errigo, P., Onorati, F., et al. Transcatheter aortic valve implantation compared with surgical aortic valve replacement in low-risk patients. Circ Cardiovasc Interv, 9, 2016, e003326.
35. Thyregod, H.G., Steinbruchel, D.A., Ihlemann, N., Nissen, H., Kjeldsen, B.J., Petursson, P., et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the All-Comers NOTION Randomized Clinical Trial. J Am Coll Cardiol 65 (2015), 2184–2194.
36. Waksman, R., Rogers, T., Torguson, R., Gordon, P., Ehsan, A., Wilson, S.R., et al. Transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis. J Am Coll Cardiol 72 (2018), 2095–2105.
37. Willson, A.B., Rodes-Cabau, J., Wood, D.A., Leipsic, J., Cheung, A., Toggweiler, S., et al. Transcatheter aortic valve replacement with the St Jude Medical Portico valve: first-in-human experience. J Am Coll Cardiol 60 (2012), 581–586.
38. Manoharan, G., Walton, A.S., Brecker, S.J., Pasupati, S., Blackman, D.J., Qiao, H., et al. Treatment of symptomatic severe aortic stenosis with a novel resheathable supra-annular self-expanding transcatheter aortic valve system. JACC Cardiovasc Interv 8 (2015), 1359–1367.
39. Verma, S., Siu, S.C., Aortic dilatation in patients with bicuspid aortic valve. N Engl J Med 370 (2014), 1920–1929.
40. Praz, F., Windecker, S., Huber, C., Carrel, T., Wenaweser, P., Expanding indications of transcatheter heart valve interventions. JACC Cardiovasc Interv 8 (2015), 1777–1796.
41. Sievers, H.H., Schmidtke, C., A classification system for the bicuspid aortic valve from 304 surgical specimens. J Thorac Cardiovasc Surg 133 (2007), 1226–1233.
42. Yoon, S.H., Sharma, R., Chakravarty, T., Miyasaka, M., Ochiai, T., Nomura, T., et al. Transcatheter aortic valve replacement in bicuspid aortic valve stenosis: where do we stand?. J Cardiovasc Surg 59 (2018), 381–391.
43. Reddy, G., Wang, Z., Nishimura, R.A., Greason, K.L., Yoon, S.H., Makkar, R.R., et al. Transcatheter aortic valve replacement for stenotic bicuspid aortic valves: systematic review and meta analyses of observational studies. Catheter Cardiovasc Interv 91 (2018), 975–983.
44. Yoon, S.H., Lefevre, T., Ahn, J.M., Perlman, G.Y., Dvir, D., Latib, A., et al. Transcatheter aortic valve replacement with early- and new-generation devices in bicuspid aortic valve stenosis. J Am Coll Cardiol 68 (2016), 1195–1205.
45. Bekeredjian, R., Grayburn, P.A., Valvular heart disease: aortic regurgitation. Circulation 112 (2005), 125–134.
46. Roy, D.A., Schaefer, U., Guetta, V., Hildick-Smith, D., Mollmann, H., Dumonteil, N., et al. Transcatheter aortic valve implantation for pure severe native aortic valve regurgitation. J Am Coll Cardiol 61 (2013), 1577–1584.
47. Seiffert, M., Bader, R., Kappert, U., Rastan, A., Krapf, S., Bleiziffer, S., et al. Initial German experience with transapical implantation of a second-generation transcatheter heart valve for the treatment of aortic regurgitation. JACC Cardiovasc Interv 7 (2014), 1168–1174.
48. Schofer, J., Nietlispach, F., Bijuklic, K., Colombo, A., Gatto, F., De Marco, F., et al. Transfemoral implantation of a fully repositionable and retrievable transcatheter valve for noncalcified pure aortic regurgitation. JACC Cardiovasc Interv 8 (2015), 1842–1849.
49. Testa, L., Latib, A., Rossi, M.L., De Marco, F., De Carlo, M., Fiorina, C., et al. CoreValve implantation for severe aortic regurgitation: a multicentre registry. EuroIntervention 10 (2014), 739–745.
50. Wei, L., Liu, H., Zhu, L., Yang, Y., Zheng, J., Guo, K., et al. A new transcatheter aortic valve replacement system for predominant aortic regurgitation implantation of the J-valve and early outcome. JACC Cardiovasc Interv 8 (2015), 1831–1841.
51. Wendt, D., Kahlert, P., Pasa, S., El-Chilali, K., Al-Rashid, F., Tsagakis, K., et al. Transapical transcatheter aortic valve for severe aortic regurgitation: expanding the limits. JACC Cardiovasc Interv 7 (2014), 1159–1167.
52. Franzone, A., Piccolo, R., Siontis, G.C., Lanz, J., Stortecky, S., Praz, F., et al. Transcatheter aortic valve replacement for the treatment of pure native aortic valve regurgitation: a systematic review. JACC Cardiovasc Interv 9 (2016), 2308–2317.
53. Bernick, C., Kuller, L., Dulberg, C., Longstreth, W.T. Jr., Manolio, T., Beauchamp, N., et al. MRI infarcts and the risk of future stroke: the cardiovascular health study. Neurology 57 (2001), 1222–1229.
54. Fairbairn, T.A., Mather, A.N., Bijsterveld, P., Worthy, G., Currie, S., Goddard, A.J., et al. Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status. Heart 98 (2012), 18–23.
55. Vermeer, S.E., Longstreth, W.T. Jr., Koudstaal, P.J., Silent brain infarcts: a systematic review. Lancet Neurol 6 (2007), 611–619.
56. Eggebrecht, H., Schmermund, A., Voigtlander, T., Kahlert, P., Erbel, R., Mehta, R.H., Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention 8 (2012), 129–138.
57. Haussig, S., Mangner, N., Dwyer, M.G., Lehmkuhl, L., Lucke, C., Woitek, F., et al. Effect of a cerebral protection device on brain lesions following transcatheter aortic valve implantation in patients with severe aortic stenosis: the CLEAN-TAVI randomized clinical trial. JAMA 316 (2016), 592–601.
58. Kapadia, S.R., Kodali, S., Makkar, R., Mehran, R., Lazar, R.M., Zivadinov, R., et al. Protection against cerebral embolism during transcatheter aortic valve replacement. J Am Coll Cardiol 69 (2017), 367–377.
59. Rogers, T., Alraies, M.C., Torguson, R., Waksman, R., Overview of the 2017 US Food and Drug Administration circulatory system devices panel meeting on the sentinel cerebral protection system. Am Heart J 192 (2017), 113–119.
60. Kapadia, S.R., Routine use of embolic protection during transcatheter aortic valve replacement. JACC Cardiovasc Interv 10 (2017), 2304–2306.
61. Seeger, J., Gonska, B., Otto, M., Rottbauer, W., Wohrle, J., Cerebral embolic protection during transcatheter aortic valve replacement significantly reduces death and stroke compared with unprotected procedures. JACC Cardiovasc Interv 10 (2017), 2297–2303.
62. Seeger, J., Kapadia, S.R., Kodali, S., Linke, A., Wohrle, J., Haussig, S., et al. Rate of peri-procedural stroke observed with cerebral embolic protection during transcatheter aortic valve replacement: a patient-level propensity-matched analysis. Eur Heart J, 2018 [Epub ahead of print].
63. Iung, B., Baron, G., Butchart, E.G., Delahaye, F., Gohlke-Barwolf, C., Levang, O.W., et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular heart disease. Eur Heart J 24 (2003), 1231–1243.
64. Asgar, A.W., Mack, M.J., Stone, G.W., Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations. J Am Coll Cardiol 65 (2015), 1231–1248.
65. Punnoose, L., Burkhoff, D., Cunningham, L., Horn, E.M., Functional mitral regurgitation: therapeutic strategies for a ventricular disease. J Card Fail 20 (2014), 252–267.
66. Baumgartner, H., Falk, V., Bax, J.J., De Bonis, M., Hamm, C., Holm, P.J., et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 38 (2017), 2739–2791.
67. Pierard, L.A., Carabello, B.A., Ischaemic mitral regurgitation: pathophysiology, outcomes and the conundrum of treatment. Eur Heart J 31 (2010), 2996–3005.
68. Feldman, T., Kar, S., Elmariah, S., Smart, S.C., Trento, A., Siegel, R.J., et al. Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST II. J Am Coll Cardiol 66 (2015), 2844–2854.
69. Sorajja, P., Mack, M., Vemulapalli, S., Holmes, D.R. Jr., Stebbins, A., Kar, S., et al. Initial experience with commercial transcatheter mitral valve repair in the United States. J Am Coll Cardiol 67 (2016), 1129–1140.
70. Buzzatti, N., Denti, P., La Canna, G., Schiavi, D., Vicentini, L., Scarfo, I.S., et al. Does implantation of a single clip provide reliable durability after transcatheter mitral repair?. Eur J Cardiothorac Surg 52 (2017), 137–142.
71. Whitlow, P.L., Feldman, T., Pedersen, W.R., Lim, D.S., Kipperman, R., Smalling, R., et al. Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) high risk study. J Am Coll Cardiol 59 (2012), 130–139.
72. Chiarito, M., Pagnesi, M., Martino, E.A., Pighi, M., Scotti, A., Biondi-Zoccai, G., et al. Outcome after percutaneous edge-to-edge mitral repair for functional and degenerative mitral regurgitation: a systematic review and meta-analysis. Heart 104 (2018), 306–312.
73. Obadia, J.F., Armoiry, X., Iung, B., Lefevre, T., Mewton, N., Messika-Zeitoun, D., et al. The MITRA-FR study: design and rationale of a randomised study of percutaneous mitral valve repair compared with optimal medical management alone for severe secondary mitral regurgitation. EuroIntervention 10 (2015), 1354–1360.
74. Obadia, J.F., Messika-Zeitoun, D., Leurent, G., Iung, B., Bonnet, G., Piriou, N., et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med 379 (2018), 2297–2306.
75. Stone, G.W., Lindenfeld, J., Abraham, W.T., Kar, S., Lim, D.S., Mishell, J.M., et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med 379 (2018), 2307–2318.
76. Tabata, N., Weber, M., Sinning, J.M., Mellert, F., Nickenig, G., Werner, N., Successful edge-to-edge mitral repair using the New MitraClip XTR system following rupture of transapical implanted neochord. JACC Cardiovasc Interv 11 (2018), e175–e177.
77. Praz, F., Spargias, K., Chrissoheris, M., Bullesfeld, L., Nickenig, G., Deuschl, F., et al. Compassionate use of the PASCAL transcatheter mitral valve repair system for patients with severe mitral regurgitation: a multicentre, prospective, observational, first-in-man study. Lancet 390 (2017), 773–780.
78. Maisano, F., Franzen, O., Baldus, S., Schafer, U., Hausleiter, J., Butter, C., et al. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol 62 (2013), 1052–1061.
79. Nickenig, G., Estevez-Loureiro, R., Franzen, O., Tamburino, C., Vanderheyden, M., Luscher, T.F., et al. Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011–2012 Pilot European Sentinel Registry. J Am Coll Cardiol 64 (2014), 875–884.
80. Feldman, T., Percutaneous mitral annuloplasty: not always a cinch. Catheter Cardiovasc Interv 69 (2007), 1062–1063.
81. Schofer, J., Siminiak, T., Haude, M., Herrman, J.P., Vainer, J., Wu, J.C., et al. Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study. Circulation 120 (2009), 326–333.
82. Rogers, J.H., Thomas, M., Morice, M.C., Narbute, I., Zabunova, M., Hovasse, T., et al. Treatment of heart failure with associated functional mitral regurgitation using the ARTO system: initial results of the first-in-human MAVERIC trial (Mitral Valve Repair Clinical Trial). JACC Cardiovasc Interv 8 (2015), 1095–1104.
83. Rogers, J.H., Boyd, W.D., Smith, T.W., Bolling, S.F., Early experience with Millipede IRIS transcatheter mitral annuloplasty. Ann Cardiothorac Surg 7 (2018), 780–786.
84. Nickenig, G., Hammerstingl, C., Schueler, R., Topilsky, Y., Grayburn, P.A., Vahanian, A., et al. Transcatheter mitral annuloplasty in chronic functional mitral regurgitation: 6-month results with the cardioband percutaneous mitral repair system. JACC Cardiovasc Interv 9 (2016), 2039–2047.
85. Messika-Zeitoun, D., Nickenig, G., Latib, A., Kuck, K.H., Baldus, S., Schueler, R., et al. Transcatheter mitral valve repair for functional mitral regurgitation using the Cardioband system: 1 year outcomes. Eur Heart J 40 (2019), 466–472.
86. Nickenig, G., Schueler, R., Dager, A., Martinez Clark, P., Abizaid, A., Siminiak, T., et al. Treatment of chronic functional mitral valve regurgitation with a percutaneous annuloplasty system. J Am Coll Cardiol 67 (2016), 2927–2936.
87. Siminiak, T., Hoppe, U.C., Schofer, J., Haude, M., Herrman, J.P., Vainer, J., et al. Effectiveness and safety of percutaneous coronary sinus-based mitral valve repair in patients with dilated cardiomyopathy (from the AMADEUS trial). Am J Cardiol 104 (2009), 565–570.
88. Perier, P., Hohenberger, W., Lakew, F., Batz, G., Urbanski, P., Zacher, M., et al. Toward a new paradigm for the reconstruction of posterior leaflet prolapse: midterm results of the “respect rather than resect” approach. Ann Thorac Surg 86 (2008), 718–725.
89. Seeburger, J., Rinaldi, M., Nielsen, S.L., Salizzoni, S., Lange, R., Schoenburg, M., et al. Off-pump transapical implantation of artificial neo-chordae to correct mitral regurgitation: the TACT Trial (Transapical Artificial Chordae Tendinae) proof of concept. J Am Coll Cardiol 63 (2014), 914–919.
90. Rucinskas, K., Janusauskas, V., Zakarkaite, D., Aidietiene, S., Samalavicius, R., Speziali, G., et al. Off-pump transapical implantation of artificial chordae to correct mitral regurgitation: early results of a single-center experience. J Thorac Cardiovasc Surg 147 (2014), 95–99.
91. Seeburger, J., Borger, M.A., Tschernich, H., Leontjev, S., Holzhey, D., Noack, T., et al. Transapical beating heart mitral valve repair. Circ Cardiovasc Interv 3 (2010), 611–612.
92. Colli, A., Manzan, E., Besola, L., Bizzotto, E., Fiocco, A., Zucchetta, F., et al. One-year outcomes after transapical echocardiography-guided mitral valve repair. Circulation 138 (2018), 843–845.
93. Colli, A., Manzan, E., Aidietis, A., Rucinskas, K., Bizzotto, E., Besola, L., et al. An early European experience with transapical off-pump mitral valve repair with NeoChord implantation. Eur J Cardiothorac Surg 54 (2018), 460–466.
94. Nielsen, S.L., Timek, T.A., Lai, D.T., Daughters, G.T., Liang, D., Hasenkam, J.M., et al. Edge-to-edge mitral repair: tension on the approximating suture and leaflet deformation during acute ischemic mitral regurgitation in the ovine heart. Circulation 104 (2001), I29–I35.
95. Timek, T.A., Nielsen, S.L., Lai, D.T., Tibayan, F., Liang, D., Daughters, G.T., et al. Mitral annular size predicts Alfieri stitch tension in mitral edge-to-edge repair. J Heart Valve Dis 13 (2004), 165–173.
96. Timek, T.A., Nielsen, S.L., Lai, D.T., Liang, D., Daughters, G.T., Ingels, N.B. Jr., et al. Effect of chronotropy and inotropy on stitch tension in the edge-to-edge mitral repair. Circulation 116 (2007), I276–I281.
97. De Bonis, M., Lapenna, E., Maisano, F., Barili, F., La Canna, G., Buzzatti, N., et al. Long-term results (
98. Mangieri, A., Colombo, A., Demir, O.M., Agricola, E., Ancona, F., Regazzoli, D., et al. Percutaneous direct annuloplasty with edge-to-edge technique for mitral regurgitation: replicating a complete surgical mitral repair in a one-step procedure. Can J Cardiol, 34, 2018, 1088 e1–2.
99. von Bardeleben, R.S., Colli, A., Schulz, E., Ruf, T., Wrobel, K., Vahl, C.F., et al. First in human transcatheter COMBO mitral valve repair with direct ring annuloplasty and neochord leaflet implantation to treat degenerative mitral regurgitation: feasibility of the simultaneous toolbox concept guided by 3D echo and computed tomography fusion imaging. Eur Heart J 39 (2018), 1314–1315.
100. Acker, M.A., Parides, M.K., Perrault, L.P., Moskowitz, A.J., Gelijns, A.C., Voisine, P., et al. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med 370 (2014), 23–32.
101. Descoutures, F., Himbert, D., Maisano, F., Casselman, F., de Weger, A., Bodea, O., et al. Transcatheter valve-in-ring implantation after failure of surgical mitral repair. Eur J Cardiothorac Surg 44 (2013), e8–e15.
102. Cheung, A., Al-Lawati, A., Transcatheter mitral valve-in-valve implantation: current experience and review of literature. Curr Opin Cardiol 28 (2013), 181–186.
103. Fassa, A.A., Himbert, D., Brochet, E., Depoix, J.P., Cheong, A.P., Alkhoder, S., et al. Transseptal transcatheter mitral valve implantation for severely calcified mitral stenosis. JACC Cardiovasc Interv 7 (2014), 696–697.
104. Hasan, R., Mahadevan, V.S., Schneider, H., Clarke, B., First in human transapical implantation of an inverted transcatheter aortic valve prosthesis to treat native mitral valve stenosis. Circulation 128 (2013), e74–e76.
105. Maisano, F., Buzzatti, N., Taramasso, M., Alfieri, O., Mitral transcatheter technologies. Rambam Maimonides Med J, 4, 2013, e0015.
106. De Backer, O., Piazza, N., Banai, S., Lutter, G., Maisano, F., Herrmann, H.C., et al. Percutaneous transcatheter mitral valve replacement: an overview of devices in preclinical and early clinical evaluation. Circ Cardiovasc Interv 7 (2014), 400–409.
107. Muller, D.W.M., Farivar, R.S., Jansz, P., Bae, R., Walters, D., Clarke, A., et al. Transcatheter mitral valve replacement for patients with symptomatic mitral regurgitation: a global feasibility trial. J Am Coll Cardiol 69 (2017), 381–391.
108. Bapat, V., Rajagopal, V., Meduri, C., Farivar, R.S., Walton, A., Duffy, S.J., et al. Early experience with new transcatheter mitral valve replacement. J Am Coll Cardiol 71 (2018), 12–21.
109. Cheung, A., Banai, S., Transcatheter mitral valve implantation: Tiara. EuroIntervention 12 (2016), Y70–Y72.
110. Ussia, G.P., Quadri, A., Cammalleri, V., De Vico, P., Muscoli, S., Marchei, M., et al. Percutaneous transfemoral-transseptal implantation of a second-generation CardiAQ mitral valve bioprosthesis: first procedure description and 30-day follow-up. EuroIntervention 11 (2016), 1126–1131.
111. Meredith, I., Bapat, V., Morriss, J., McLean, M., Prendergast, B., Intrepid transcatheter mitral valve replacement system: technical and product description. EuroIntervention 12 (2016), Y78–Y80.
112. Stuge, O., Liddicoat, J., Emerging opportunities for cardiac surgeons within structural heart disease. J Thorac Cardiovasc Surg 132 (2006), 1258–1261.
113. Taramasso, M., Vanermen, H., Maisano, F., Guidotti, A., La Canna, G., Alfieri, O., The growing clinical importance of secondary tricuspid regurgitation. J Am Coll Cardiol 59 (2012), 703–710.
114. Buzzatti, N., Iaci, G., Taramasso, M., Nisi, T., Lapenna, E., De Bonis, M., et al. Long-term outcomes of tricuspid valve replacement after previous left-side heart surgery. Eur J Cardiothorac Surg 46 (2014), 713–719.
115. Nath, J., Foster, E., Heidenreich, P.A., Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 43 (2004), 405–409.
116. Leviner, D.B., Medalion, B., Baruch, I., Sagie, A., Sharoni, E., Fuks, A., et al. Tricuspid valve replacement: the effect of gender on operative results. J Heart Valve Dis 23 (2014), 209–215.
117. Natarajan, D., Joseph, J., Denti, P., Redwood, S., Prendergast, B., The big parade: emerging percutaneous mitral and tricuspid valve devices. EuroIntervention 13 (2017), AA51–AA59.
118. Rodes-Cabau, J., Hahn, R.T., Latib, A., Laule, M., Lauten, A., Maisano, F., et al. Transcatheter therapies for treating tricuspid regurgitation. J Am Coll Cardiol 67 (2016), 1829–1845.
119. Nickenig, G., Kowalski, M., Hausleiter, J., Braun, D., Schofer, J., Yzeiraj, E., et al. Transcatheter treatment of severe tricuspid regurgitation with the edge-to-edge MitraClip technique. Circulation 135 (2017), 1802–1814.
120. Perlman, G., Praz, F., Puri, R., Ofek, H., Ye, J., Philippon, F., et al. Transcatheter tricuspid valve repair with a new transcatheter coaptation system for the treatment of severe tricuspid regurgitation: 1-year clinical and echocardiographic results. JACC Cardiovasc Interv 10 (2017), 1994–2003.
121. Braun, D., Nabauer, M., Orban, M., Orban, M., Gross, L., Englmaier, A., et al. Transcatheter treatment of severe tricuspid regurgitation using the edge-to-edge repair technique. EuroIntervention 12 (2017), e1837–e1844.
122. Schueler, R., Ozturk, C., Sinning, J.M., Werner, N., Welz, A., Hammerstingl, C., et al. Impact of baseline tricuspid regurgitation on long-term clinical outcomes and survival after interventional edge-to-edge repair for mitral regurgitation. Clin Res Cardiol 106 (2017), 350–358.
123. Kalbacher, D., Schafer, U., von Bardeleben, R.S., Zuern, C.S., Bekeredjian, R., Ouarrak, T., et al. Impact of tricuspid valve regurgitation in surgical high-risk patients undergoing MitraClip implantation: results from the TRAMI registry. EuroIntervention 12 (2017), e1809–e1816.
124. von Bardeleben, R.S., Ruf, T., Schulz, E., Muenzel, T., Kreidel, F., First percutaneous COMBO therapy of tricuspid regurgitation using direct annuloplasty and staged edge-to-edge repair in a surgical-like Clover technique. Eur Heart J 39 (2018), 3621–3622.
125. Sugiura, A., Weber, M., Sinning, J.M., Werner, N., Nickenig, G., Staged transcatheter valve repair via MitraClip XTR after Cardioband for tricuspid regurgitation. Eur Heart J Cardiovasc Imaging, 20, 2019, 118.
126. Mack, M.J., Leon, M.B., Smith, C.R., Miller, D.C., Moses, J.W., Tuzcu, E.M., et al. PARTNER 1 trial investigators 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385 (2015), 2477–2484.